Key points are not available for this paper at this time.
Level 5 evidence on critical pathways leaves open optimal implementation; randomized trials needed before practice change.
From the Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Disclosures posted at http://www.timi.org. Reprints: Christopher P. Cannon, MD, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115. E-mail: [email protected].
No takes yet. Share an insight, caveat, or question.
Christopher P. Cannon (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: